Ignite Creation Date:
2025-12-25 @ 4:18 AM
Ignite Modification Date:
2025-12-26 @ 3:18 AM
Study NCT ID:
NCT01975220
Status:
COMPLETED
Last Update Posted:
2017-03-08
First Post:
2013-10-29
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Relative Bioavailability of 2 Fixed Dose Combinations of Empagliflozin/Metformin Compared With Single Tablets
Sponsor:
Boehringer Ingelheim
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-10
Start Date Type:
None
Primary Completion Date:
2013-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-12
Completion Date Type:
ACTUAL
First Submit Date:
2013-10-29
First Submit QC Date:
None
Study First Post Date:
2013-11-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-01-18
Results First Submit QC Date:
None
Results First Post Date:
2017-03-08
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-01-18
Last Update Post Date:
2017-03-08
Last Update Post Date Type:
ACTUAL